1.
|
You state on pages 26, 27, and
elsewhere that you intend to sell your products in the newer markets in
Middle East, Africa, and Latin America, regions generally understood to
include Iran, Syria, and Cuba. Iran, Syria, Sudan and Cuba are identified
by the State Department as state sponsors of terrorism, and are subject to
U.S. economic sanctions and export controls. We note that your Form 10-K
does not include disclosure regarding contacts with Iran, Syria, Sudan or
Cuba. Please describe to us the nature and extent of your past, current
and anticipated contacts with Iran, Syria, Sudan and Cuba, if any, whether
through subsidiaries, joint ventures, distributors or other direct or
indirect arrangements. Your response should describe any products,
components, equipment, technology, software, services information and
support that you have provided to Iran, Syria, Sudan and Cuba, directly or
indirectly, and any agreements, commercial arrangements, or other contacts
you have had with the governments of those countries or entities
controlled by these
governments.
|
2.
|
In your response letter,
please describe the basis for your determination that disclosure relating
to the litigation referenced on page F-34 was not required by Item 103 of
Regulation S-K.
|
3.
|
For each unregistered
offering, please revise to clarify the section of the Securities Act or
the rule of the Commission under which exemption from registration is
claimed and state briefly the facts relied upon to make the exemption
available. See Item 701(d) of Regulation S-K. Please note that this
comment also applies to your quarterly report on Form 10-Q for the quarter
ended September 30, 2010.
|
4.
|
Here and in your quarterly
report on Form 10-Q for the quarter ended September 30, 2010, you indicate
that certain of your unregistered sales of securities were made based on a
claim of exemption under Regulation D. However, you do not appear to have
filed any Forms D in connection with these offerings. Please note that as
of March 16, 2009, Forms D are required to be submitted electronically on
EDGAR. Please file the required Forms D for any sales made in reliance on
Regulation D after this date, or tell us in your response letter why no
such filings are required. See Rule 503 of Regulation D, SEC Release NO.
33-8891, and the additional guidance provided by the Division of
Corporation Finance at: http://www.sec.gov/divisions/corpfin/formdfiling.htm and http://www.sec.gov/info/smallbus/secg/formdguide.htm.
|
5.
|
We note your critical
accounting policy and footnote disclosures regarding goodwill impairment
testing. Tell us your consideration of providing enhanced disclosure that
more fully describe the estimates and assumptions included in your
assessment and evaluation of goodwill impairment. In this respect, we have
identified the following areas where we believe additional discussion
would enhance your
disclosures:
|
|
·
|
Please disclose your annual
goodwill impairment test date. Discuss the reporting units used in your
analysis and explain how the reporting units were identified. Provide the
amount of goodwill allocated to each reporting unit and explain in greater
detail how you estimate the fair value of each reporting
unit.
|
Reporting Units
|
2010
|
2009
|
||||||
Asia
Pacific
|
$ | 1,303,372 | $ | 1,303,372 | ||||
Europe
|
3,471,813 | 3,471,813 | ||||||
North
America
|
4,664,100 | 4,664,100 | ||||||
Total
|
$ | 9,439,285 | $ | 9,439,285 |
Reporting Units
|
Percentage by which fair
value exceeds carrying
value
|
|||
Asia
Pacific
|
92.78 | % | ||
Europe
|
62.28 | % | ||
North
America
|
15.3 | % |
|
·
|
To the extent that any of your
reporting units have estimated fair values that are not substantially in
excess of the carrying values and are potentially at risk of failing step
one of your goodwill impairment analysis please tell us and disclose the
percentage by which the fair value substantially exceeds the carrying
value for all your reporting units, please disclose this
determination.
|
|
·
|
For those reporting units in
which the fair values do not exceed their carrying values by significant
amounts, describe the potential events and/or changes in circumstances
that could reasonably be expected to negatively affect the key assumptions
used in determining fair
value.
|
6.
|
Tell us your consideration of
providing enhanced disclosures to explain the underlying reasons for your
significant revenue growth. In this respect, you should clearly explain
why there was such a significant increase in your license fee revenues. We
refer you to Section III.B of SEC Release
33-8350.
|
7.
|
Please tell us how you
considered discussing the extent to which changes in revenues from period
to period were due to changes in prices or changes in the volume of
products sold and services provided. See Item 303(a)(3)(iii) of Regulation
S-K. Please note that this comment also applies to your filing on Form
10-Q for the quarter ended September 30,
2010.
|
8.
|
Please clarify what you mean
by your statement on page 32 that “due to the revision in your pricing
policy, NFS™ license value in APAC is in the range of $1.0 to $2.0
million, without factoring in services maintenance and implementation
fees.” In addition, explain the reason for the change in your pricing
policy, or why you concluded that such disclosure is not
required.
|
9.
|
Tell us your consideration of
providing enhanced disclosures that focus on primary drivers of and other
material factors necessary to an understanding of your cash flows. In this
regard, we note that there were material changes in several working
capital line items, however, you have not disclosed why these changes
occurred and how they impacted operating cash flow. Also, tell us how you
considered disclosing the days sales outstanding (“DSO”) at each balance
sheet date and the impact it has on your cash flows. You should also
consider disclosing the impact that your convertible debt and loans
payable will have on your future cash flows. We refer you to Section IV.B
of SEC Release No. 33-8350.
|
10.
|
We
note from your disclosures on page F-27 that the cumulative amount of
undistributed earnings of foreign subsidiaries that you intend to
permanently invest and upon which no U.S. income taxes has been provided
is $21.7 million as of June 30, 2010. Please tell us how you considered
providing liquidity disclosures to disclose the potential tax impact
associated with the repatriation of the undistributed earnings. In this
regard, consider disclosing the amount of cash that is currently held by
your foreign subsidiaries. We refer you to Item 303(a)(1) of Regulation
S-K and Section IV of SEC Release
33-8350.
|
11.
|
Please tell us what
consideration you gave to including a more detailed discussion of the
financial covenants in your bank loans, their impact on your liquidity and
capital resources, and the status of your compliance with the covenants.
Please note that this comment also applies to your filing on Form 10-Q for
the quarter ended September 30,
2010.
|
12.
|
We note that this section does
not include the disclosure required by Item 9A of Form 10-K. Given the
nature and extent of this omission, please tell us whether you consider
your Form 10-K to be timely
filed.
|
13.
|
We are unable to locate
disclosures responsive to Items 406, 407(d)(4) and 407(d)(5) of Regulation
S-K in your Form 10-K or amended Form 10-K. See Item 10 of Form 10-K.
Please revise or advise us why this information is not
provided.
|
14.
|
In your amended filing,
include a more detailed description of the specific experience,
qualifications, attributes or skills that led to the conclusion that each
nominee should serve as your director at the time that the disclosure is
made, in light of your business and structure. See Item 401(e)(1) of
Regulation S-K.
|
15.
|
Please revise your disclosure
in this section to explain why base salaries were adjusted for each of
your named executive officers for the past fiscal year. See Item 402(m)(l)
of Regulation S-K.
|
16.
|
Please revise your discussion
in this section to provide a more detailed discussion of the
performance-based cash bonus component of your compensation program, as
well as why none of your named executive officers were awarded cash
bonuses for your fiscal year ended June 30, 2010. Seem Item 402(m)(l) of
Regulation S-K.
|
17.
|
Please revise your discussion
in this section to provide a detailed discussion explaining how you
determined the amount of stock awarded to each named executive officer
during the fiscal year ended June 30, 2010. See Item 402(m)(l) of
Regulation S-K.
|
|
The
disclosure in this section, on page 46 of the 10-K/A, has been revised to
explain how we determined the amount of stock awarded to each named
executive officer as follows:
|
18.
|
It is unclear why your
disclosure in footnote 2 is not included in the table itself. It appears
that the dollar amount of the option grants, determined in accordance with
FASB ASC Topic 718 should be set forth in column (f), and correspondingly
changes should be made to column (j). See Item 402(n)(2)(vi) of Regulation
S-K and the guidance provide in Section II.A.2.d. of SEC Release no.
33-9089. Please revise or
advise.
|
19.
|
It appears that you have
effective registration statements on Form S-3 and S-8 including, without
limitation File Nos. 333-140248, 333-138103 and 333-142054, that
incorporate by reference from your annual report. You have not, however,
included a written consent from your independent auditors as an exhibit to
your filing. Please file the written consent as an exhibit to your amended
Form 10-K. See Item 601(b)(23)(ii) of Regulation S-K. If any offerings on
form S-3 or S-8 have been completed or otherwise terminated, please
advise, and file a post effective amendment consistent with Securities Act
Rule 415.
|
20.
|
We note that your Form 10-K
has not been signed by your CFO, Boo-Ali Siddiqui, in his individual
capacity. See paragraph 2(a) of General Instruction D to Form 10-K. Please
file an amended Form 10-K that is properly
signed.
|
21.
|
We note that you did not
identify the person signing the report on Form 10-K in the capacity of
controller or principal accounting officer. See paragraph 2(a) of General
Instruction D to form 10-K. Note that any person who occupies more than
one specified positions must indicate each capacity in which he or she
signs the report. See paragraph 2(b) of General Instruction D to Form
10-K. Please include the signature of your controller or principal
accounting officer in your amended Form 10-K. Please note that this
comment also applies to your amended 10-K filed on September 14,
2010.
|
|
The
Form 10-K, as amended on September 14, 2010, has been amended to reflect
the above comment denoting Mr. Boo-Ali Siddiqui as the principal
accounting officer of the Company.
|
22.
|
Please tell us how your
disclosures comply with ASC 810-10-55-4J. In this regard, we note the
line-item description “net income (loss) before non-controlling interest
in subsidiary and income taxes” in the consolidated statement of
operations appears to include income (loss) from the non-controlling
interest and therefore appears to represent “net income (loss)” if
presented after tax. We also note that the line item currently labeled as
“Net income (loss)” appears to represent “Net income attributable to
NetSol.” Please revise or tell us why revision is not
warranted.
|
23.
|
Please tell us how you
considered FASB ASC 230-10-45-28, which indicates that the statement of
cash flows prepared under the indirect method should start with “net
income (loss).” In this respect, please note that ASC 810-10-65-1 defines
“net income” as attributable to both the controlling and non-controlling
interests.
|
For
the year
|
||||||||
Ended
June 30,
|
||||||||
2010
|
2009
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
income (loss)
|
$ | 6,286,217 | $ | (6,230,905 | ) | |||
Adjustments
to reconcile net income (loss) to net cash provided by operating
activities:
|
||||||||
Depreciation
and amortization
|
3,907,945 | 4,188,208 | ||||||
Provision
for bad debts
|
442,804 | 2,393,685 | ||||||
Gain
on sale of subsidiary shares in Pakistan
|
- | (351,522 | ) | |||||
Loss
on foreign currency exchange transaction
|
4,144 | - | ||||||
Share
of net loss from investment under equity method
|
67,494 | - | ||||||
Loss
on sale of assets
|
224,741 | 404,820 | ||||||
Stock
issued for notes payable and related interest
|
39,960 | - | ||||||
Stock
issued for services
|
801,684 | 346,817 | ||||||
Fair
market value of warrants and stock options granted
|
803,508 | 261,472 | ||||||
Beneficial
conversion feature
|
1,867,787 | 40,277 | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Increase/
decrease in accounts receivable
|
(1,316,995 | ) | (4,679,496 | ) | ||||
Increase/
decrease in other current assets
|
(3,701,022 | ) | 3,740,567 | |||||
Increase/
decrease in long-term assets
|
- | 43,889 | ||||||
Increase/
decrease in accounts payable and accrued expenses
|
(758,557 | ) | 1,073,775 | |||||
Net
cash provided by operating activities
|
8,669,710 | 1,231,588 | ||||||
Cash
flows from investing activities:
|
||||||||
Purchases
of property and equipment
|
(2,986,495 | ) | (2,093,618 | ) | ||||
Sales
of property and equipment
|
641,484 | 65,096 | ||||||
Payments
of acquisition payable
|
- | (742,989 | ) | |||||
Investment
under equity method
|
(268,000 | ) | - | |||||
Increase
in intangible assets
|
(7,603,779 | ) | (6,662,774 | ) | ||||
Net
cash used in investing activities
|
(10,216,790 | ) | (9,434,284 | ) | ||||
Cash
flows from financing activities:
|
||||||||
Proceeds
from sale of common stock
|
854,509 | 712,770 | ||||||
Proceeds
from the exercise of stock options and warrants
|
71,250 | 563,929 | ||||||
Purchase
of subsidary stock in Pakistan
|
- | (281,347 | ) | |||||
Proceeds
from sale of subsidiary stock
|
- | 558,535 | ||||||
Purchase
of treasury stock
|
- | (360,328 | ) | |||||
Proceeds
from convertible notes payable
|
3,500,000 | 6,000,000 | ||||||
Redemption
of preferred stock
|
(1,920,000 | ) | - | |||||
Restricted
cash
|
(700,000 | ) | (5,000,000 | ) | ||||
Dividend
Paid
|
(43,828 | ) | (33,508 | ) | ||||
Bank
overdraft
|
(7,008 | ) | 159,551 | |||||
Proceeds
from bank loans
|
4,540,971 | 3,843,541 | ||||||
Payments
on bank loans
|
(258,358 | ) | 947,870 | |||||
Payments
on capital lease obligations & loans - net
|
(4,328,700 | ) | (539,497 | ) | ||||
Net
cash provided by financing activities
|
1,708,837 | 6,571,516 | ||||||
Effect
of exchange rate changes in cash
|
(489,973 | ) | (240,296 | ) | ||||
Net
increase in cash and cash equivalents
|
(328,216 | ) | (1,871,477 | ) | ||||
Cash
and cash equivalents, beginning of year
|
4,403,762 | 6,275,238 | ||||||
Cash
and cash equivalents, end of year
|
$ | 4,075,546 | $ | 4,403,762 |
24.
|
Please clarify how you
determine that collectability of your accounts receivable is reasonably
assured pursuant to Section 13(A)(1) and footnote 6 of FASB ASC
605-10-S99. Please tell us and disclose your typical payment terms and
clarify whether you generally receive payment within these terms. As part
of your response, please provide us your DSO for each of the periods
presented.
|
25.
|
We note your percentage of
completion arrangements result in “revenues in excess of billings” Please
tell us how you consider the collectability criteria and the fixed and
determinable criteria when recognizing revenue from these arrangements. As
part to your response, please tell us the extent to which you have
successfully billed and collected these amounts subsequent to the balance
sheet date.
|
26.
|
Please clarify how you
determine the functional currency for each of your subsidiaries. Provide
an analysis that demonstrates the functional currency is the currency of
the primary economic environment in which the entity operates, normally
the currency in which the operation generates and expends cash. We refer
you to the guidance in FASB ASC 830-10-45-2 through 830-10-45-6 and
830-10-55-3 through
830-10-5-7.
|
27.
|
Please tell us and revise in
future filings to disclose the weighted average amortization period in
total and by major intangible asset class. See FASB ASC
350-30-50-1.
|
Product Licenses
|
Customer Lists
|
Total
|
||||||||||
Intangible
assets - June 30, 2008 - cost
|
$ | 18,992,284 | $ | 5,451,094 | $ | 24,443,378 | ||||||
Additions
|
6,050,047 | 352,963 | 6,403,010 | |||||||||
Effect
of translation adjustment
|
(1,880,317 | ) | - | (1,880,317 | ) | |||||||
Accumulated
amortization
|
(9,359,407 | ) | (4,460,038 | ) | (13,819,445 | ) | ||||||
Net
balance - June 30, 2009
|
$ | 13,802,607 | $ | 1,344,019 | $ | 15,146,626 | ||||||
Intangible
assets - June 30, 2009 - cost
|
$ | 25,042,331 | $ | 5,804,057 | $ | 30,846,388 | ||||||
Additions
|
7,652,707 | - | 7,652,707 | |||||||||
Effect
of translation adjustment
|
(2,734,235 | ) | - | (2,734,235 | ) | |||||||
Accumulated
amortization
|
(10,958,723 | ) | (5,137,482 | ) | (16,096,205 | ) | ||||||
Net
balance - June 30, 2010
|
$ | 19,002,080 | $ | 666,575 | $ | 19,668,655 | ||||||
Weighted
average amortization period
|
7.58 | 5.00 | 7.16 | |||||||||
Amortization
expense for:
|
||||||||||||
Year
ended June 30, 2010
|
$ | 1,716,504 | $ | 677,444 | $ | 2,393,948 | ||||||
Year
ended June 30, 2009
|
$ | 1,662,424 | $ | 741,705 | $ | 2,404,129 |
28.
|
Please tell us how you
considered disclosing the amount of goodwill for each reportable segment.
We refer you to the guidance of FASB ASC
350-20-50.
|
29.
|
We note from your disclosures
on page 16 that your Pakistan operations contributed 58.18% of your 2010
revenues. Please tell us your consideration of separately disclosing
within your segment disclosures the amount of revenues or assets
attributable to each material foreign country. We refer you to the
guidance in FASB ASC
280-10-50-41.
|
June 30, 2010
|
June 30, 2009
|
|||||||||||||||
Revenue
|
Long-lived Assets
|
Revenue
|
Long-lived Assets
|
|||||||||||||
China
|
$ | 11,500,798 | $ | 45,570 | $ | 4,392,279 | $ | 54,684 | ||||||||
Thailand
|
4,975,571 | 179,125 | 1,362,749 | - | ||||||||||||
USA
|
5,805,502 | 6,524,366 | 5,396,693 | 8,190,837 | ||||||||||||
UK
|
5,937,566 | 5,125,867 | 6,984,690 | 5,849,396 | ||||||||||||
Pakistan
|
1,994,993 | 26,701,772 | 2,629,049 | 19,673,740 | ||||||||||||
Australia
|
1,066,013 | 4,158 | 1,916,766 | 3,417 | ||||||||||||
Other
Countries
|
5,499,454 | - | 3,765,951 | - | ||||||||||||
Total
|
$ | 36,779,897 | $ | 38,580,858 | $ | 26,448,177 | $ | 33,772,074 |
30.
|
Please tell us how your
disclosures comply with FASB ASC 810-10-50-1A(c and (d). Also see the
examples in FASB ASC 810-10-55-4(L) and
(M).
|
31.
|
The certifications may not be
changed in any respect from the language of Item 601(b)(31) of Regulation
S-K, even if the change would appear to be inconsequential in nature. See
Section II.B.4 of SEC Release 34-46427. We note that you have made the
following changes:
|
|
·
|
Replaced the word “report”
with “quarterly report” and “annual report” in paragraph
2;
|
|
·
|
Replaced the word “report”
with “annual report” in paragraph
3;
|
|
·
|
Deleted the language
pertaining to internal control over financial reporting in paragraph
4:
|
|
·
|
Omitted paragraph 4(b) of item
601(b(31);
|
|
·
|
Modified the language of
paragraph 4(d) of Item 601(b)(31);
and
|
|
·
|
Included paragraph 6, which is
not required by Item
601(b)(31).
|
32.
|
We note you conduct a
significant portion of your operations outside of the United States. In
order to enhance our understanding of how you prepare your financial
Statements and assess your internal control over financial reporting,
please address the
following:
|
|
·
|
In connection with your
process to determine whether your internal control over financial
reporting was effective, please describe whether and how you considered
controls to assess financial reporting risks that are relevant to all
locations where you have
operation.
|
|
·
|
If you have an internal audit
function, please describe it and explain how, if at all, that function
impacted your evaluation of your internal control over financial
reporting.
|
|
·
|
If you maintain your books and
records of your foreign subsidiaries in accordance with U.S. GAAP,
describe the controls you maintain to ensure that the activities you
conduct and the transactions you consummate are recorded in accordance
with U.S. GAAP.
|
|
·
|
If you do not maintain the
books and records of your foreign subsidiaries in accordance with U.S.
GAAP, tell us what basis of accounting you use and describe the process
you go through to convert your books and records to U.S. GAAP for SEC
reporting. Describe the controls you maintain to ensure that you have all
necessary and appropriate adjustments in your conversions and
disclosures.
|
33.
|
We would like to understand
more about the background of the people who are primarily responsible for
preparing and supervising the preparation of your financial statements and
evaluating the effectiveness of your internal control over financial
reporting and their knowledge of U.S. GAAP and SEC rules and regulations.
Do not identify by name, but for each person, please tell
us:
|
|
·
|
What role he or she takes in
preparing your financial statements and evaluating the effectiveness of
your internal control;
|
|
·
|
What relevant education and
ongoing training he or she has had relating to U.S.
GAAP;
|
|
·
|
The nature of his or her
contractual or other relationships to
you;
|
|
·
|
Whether he or she holds and
maintains any professional designations such as Certified public
Accountant (U.S.) or Certified managements Accountant;
and
|
|
·
|
About his or her professional
experience, including experience in preparing and/or auditing financial
statements prepared in accordance with U.S. GAAP and evaluating
effectiveness of internal control over financial
reporting.
|
34.
|
If you retain an accounting
firm or other similar organization to prepare your financial statements or
evaluate your internal control over financial reporting, please tell
us:
|
|
·
|
The name and address of the
accounting firm or
organization;
|
|
·
|
The qualifications of their
employee who performs the services for your
company;
|
|
·
|
How and why they are qualified
to prepare your financial statements or evaluate your internal control
over financial reporting;
|
|
·
|
How many hours they spent last
year performing these services for you;
and
|
|
·
|
The total amount of fees
you’ve paid to each accounting firm or organization with the evaluation of
internal control over financial reporting for the most recent fiscal year
end.
|
35.
|
If you retain individuals who
are not your employees and are not employed by an accounting firm or other
similar organization to prepare your financial statements or evaluate your
internal control over financial reporting, do not provide us with their
names, but tell us:
|
|
·
|
Why you believe they are
qualifies to prepare your financial statements or evaluate your internal
control over financial
reporting;
|
|
·
|
How many hours they spent last
year per forming these services for you;
and
|
|
·
|
The total amount of fees
you’re paid each individual in connection with the preparation of your
financial statements and in connection with the evaluation of your
internal control over financial reporting for the most recent fiscal year
end.
|
36.
|
Since you do not appear to
have identified an audit committee financial expert in your filing, please
describe the extent of the audit committee’s knowledge of U.S. GAAP and
internal control over financial
reporting.
|
37.
|
We note your statement that
under the supervision and participation of management, including the Chief
Executive Officer and Chief Financial Officer, you performed an assessment
of the effectiveness of your internal controls over financial reporting
“as of July 3, 2010.” Similarly, you state that the have been no
significant changes in your internal controls over financial reporting
during your “fourth fiscal quarter ended July 3, 2010.” Management’s
annual report on the effectiveness of internal controls must as of the end
of the registrant’s most recent fiscal year. See Item 308(a)(3) of
Regulation S-K. Similar concerns apply to your disclosure that there were
no changes during your fourth fiscal quarter ended July 3, 2010. Please
revise your disclosures
accordingly.
|
38.
|
As noted above in comment 31,
the certifications may not be changed in any respect from the language of
Item 601(b)(31) of Regulation S-K. See Section II.B.4 of SEC Release NO.
34-46427. We note that you have made the following
changes:
|
|
·
|
Included the company’s
signature, not the required individual’s signatures;
and
|
|
·
|
Included a disclaimer after
the signature block.
|
39.
|
We note that you have checked
the box for Non-accelerated filer instead of Smaller reporting company. In
your response letter, please provide us with an analysis explaining why
you no longer meet the definition of Smaller reporting company. Refer to
Exchange Act Rule 12b-2.
|
40.
|
As noted above in comments 31
and 38, the certifications may not be changed in any respect from the
language of Item 601(b)(31) of Regulation S-K. See Section II.B.4 of SEC
Release 34-46427. We note that you have made the following
changes:
|
|
·
|
Replaced the word “report”
with “quarterly report” in paragraphs 2 and
3;
|
|
·
|
Deleted the language
pertaining to internal control over financial reporting in paragraph
4;
|
|
·
|
Omitted the paragraph 4(b) of
Item 601(b)(31); and
|
|
·
|
Modified the language of
paragraph 4(d) of Item
601(b)(31).
|
·
|
The
company is responsible for adequacy and accuracy of the disclosure in the
filing:
|
·
|
Staff
comments or changes to disclosure in response to staff comments do not
foreclose the Commission from taking any action with respect to the
filing; and,
|
·
|
The
company may not assert staff comments as a defense in any proceeding
initiated by the Commission or any person under the federal securities
laws of the United States.
|